LncRNA HOTTIP impacts the proliferation and differentiation of fibroblast-like synoviocytes in ankylosing spondylitis through the microRNA-30b-3p/PGK1 axis

[1] Saha A(2021)Phenotypic characterization of circulating endothelial cells induced by inflammation and oxidative stress in ankylosing spondylitis Free Radic Res 55 520-532

[2] Bagchi A(2014)Incidence and predictors of morphometric vertebral fractures in patients with ankylosing spondylitis Arthritis Res Ther 16 R124-e1208

[3] Chatterjee S(2013)Treatment of spinal fractures in ankylosing spondylitis Orthopedics 36 e1203-404

[4] Dutta S(2021)Ankylosing spondylitis: an autoimmune or autoinflammatory disease? Nat Rev Rheumatol 17 387-8542

[5] Misra S(2016)A possible role of intestinal microbiota in the pathogenesis of ankylosing spondylitis Int J Mol Sci 17 2126-2285

[6] Bhattacharjee D(2019)Advances in nanomedicine for the treatment of ankylosing spondylitis Int J Nanomedicine 14 8521-4586

[7] Kang KY(2015)Update on ankylosing spondylitis: current concepts in pathogenesis Curr Allergy Asthma Rep 15 489-4249

[8] Kim IJ(2020)Drug treatment of ankylosing spondylitis and related complications: an overlook review Ann Palliat Med 9 2279-11420

[9] Jung SM(2020)Long noncoding MIAT acting as a ceRNA to sponge microRNA-204-5p to participate in cerebral microvascular endothelial cell injury after cerebral ischemia through regulating HMGB1 J Cell Physiol 235 4571-2887

[10] Kwok SK(2019)Overexpression of long noncoding RNAs (lncRNA) NF-kappabeta-interacting long noncoding RNA (NKILA) in ankylosing spondylitis is correlated with transforming growth factor beta1 (TGF-beta1), active disease and predicts length of treatment Med Sci Monit 25 4244-661

[1] Saha A(2021)Phenotypic characterization of circulating endothelial cells induced by inflammation and oxidative stress in ankylosing spondylitis Free Radic Res 55 520-532

[2] Bagchi A(2014)Incidence and predictors of morphometric vertebral fractures in patients with ankylosing spondylitis Arthritis Res Ther 16 R124-e1208

[3] Chatterjee S(2013)Treatment of spinal fractures in ankylosing spondylitis Orthopedics 36 e1203-404

[4] Dutta S(2021)Ankylosing spondylitis: an autoimmune or autoinflammatory disease? Nat Rev Rheumatol 17 387-8542

[5] Misra S(2016)A possible role of intestinal microbiota in the pathogenesis of ankylosing spondylitis Int J Mol Sci 17 2126-2285

[6] Bhattacharjee D(2019)Advances in nanomedicine for the treatment of ankylosing spondylitis Int J Nanomedicine 14 8521-4586

[7] Kang KY(2015)Update on ankylosing spondylitis: current concepts in pathogenesis Curr Allergy Asthma Rep 15 489-4249

[8] Kim IJ(2020)Drug treatment of ankylosing spondylitis and related complications: an overlook review Ann Palliat Med 9 2279-11420

[9] Jung SM(2020)Long noncoding MIAT acting as a ceRNA to sponge microRNA-204-5p to participate in cerebral microvascular endothelial cell injury after cerebral ischemia through regulating HMGB1 J Cell Physiol 235 4571-2887

[10] Kwok SK(2019)Overexpression of long noncoding RNAs (lncRNA) NF-kappabeta-interacting long noncoding RNA (NKILA) in ankylosing spondylitis is correlated with transforming growth factor beta1 (TGF-beta1), active disease and predicts length of treatment Med Sci Monit 25 4244-661